TABLE 3

Total fraction excreted (fe, Total; eq. 6) by the ablated transport pathway in each animal model and the corresponding experimentally observed fold change in hepatic metabolite concentration in animal models lacking various transporter proteins

Positive fold Δ values indicate an increase in exposure, whereas decreased exposure is denoted by a negative fold Δ value. All data points were calculated using mean values reported in the literature (Takenaka et al., 1995; Xiong et al., 2002; Nezasa et al., 2006; Zamek-Gliszczynski et al., 2006b,c). Hepatic concentrations were not quantified for carboxydichlorofluorescein (Nezasa et al., 2006) and were not reported for E3040 sulfate and E3040 glucuronide (Takenaka et al., 1995).


Metabolite

Mrp2-Deficient Rat

Mrp2-Knockout Mouse

Bcrp-Knockout Mouse

P-gp-Knockout Mouse

Mrp3-Knockout Mouse

Mrp4-Knockout Mouse
fe, Total
Fold Δ
fe, Tota
Fold Δ
fe, Tota
Fold Δ
fe, Tota
Fold Δ
fe, Tota
Fold Δ
fe, Tota
Fold Δ
AS 0.43 -1.1 0.03 -1.2 0.38 1.3 0.02 -1.3 0.14 -1.2 0.21 -1.1
AG 0.73 2.4 0.70 -3.0 0.44 1.2 0.14 1.1 0.95 6.1 0.31 -1.1
4MUS ND ND 0.43 -1.9 0.44 1.6 0.17 -1.4 0.40 1.5 0.60 1.8
4MUG ND ND 0.35 -1.4 0.43 1.2 0.42 -1.6 0.67 2.4 0.32 -1.3
HS ND ND 0.04 -1.2 0.23 1.3 0.22 -1.4 0.10 -1.4 0.28 -1.2
HG
ND
ND
0.15
1.1
0.23
1.2
0.22
1.0
0.10
1.0
0.06
1.1
  • P-gp, P-glycoprotein; AS, acetaminophen sulfate; AG, acetaminophen glucuronide; 4MUS, 4-methylumbelliferyl sulfate; HS, harmol sulfate; HG, harmol glucuronide; ND, not determined.